Health news
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application for ruxolitinib cream, a topical Janus kinase inhibitor, for the treatment of patients 12 years of age and older…
The Food and Drug Administration (FDA) has taken additional steps to strengthen the safety requirements for breast implants. The new FDA order restricts the sale and distribution of breast implants to health care providers and…
The Food and Drug Administration has granted 501(k) clearance to Prelivia, a neurostimulation device to promote healthy blood circulation and maintain healthy tissue for individuals who are bedridden or chair bound. Prelivia utilizes neurostimulation technology…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021